Aktana

company

About

Aktana delivers data-fueled insights and suggestions to life science sales reps, driving better decision-making and improved results.

  • 251 - 500

Details

Last Funding Type
Series D
Industries
Analytics,Artificial Intelligence,Life Science,Machine Learning
Founded date
Jan 1, 2008
Number Of Employee
251 - 500
Operating Status
Active

Aktana helps life science companies get the most out of artificial intelligence for commercializing their products. Its platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results.

The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$21.07M
Aktana has raised a total of $21.07M in funding over 2 rounds. Their latest funding was raised on Sep 4, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 4, 2020 Series D 1 Detail
Sep 26, 2018 Series C $21.07M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Aktana is funded by 2 investors. Norwest Venture Partners and Various Investors are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Series D
Various Investors Series C